|
Senator Says Medicare Policy Could Harm Dialysis Patients in Kentucky
|
FRANKFORT, Ky., Feb. 1 /U.S. Newswire/ -- A new Medicare proposal
restricting access to the most widely used medication for kidney
dialysis patients who need vitamin D therapy has the potential to
harm patients, Kentucky Senate President Pro Tem Richard L. "Dick"
Roeding (R-Lakeside Park) said today.
"This policy is an insult, and potentially adds injury, to
patients in Kentucky," said Sen. Roeding. "It would deny Medicare
beneficiaries access to the drug that is most widely prescrib...
Related newspaper, magazine, and journal articles from HighBeam Research